Company news
Panbela Therapeutics, Inc. news in 2020
Panbela Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
August 28, 2020
Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results
August 11, 2020
Sun BioPharma, Inc. Appoints Jennifer K. Simpson, Ph.D., as President and CEO
July 16, 2020
Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP-101
June 30, 2020
Sun BioPharma, Inc. Provides a Business Update and Reports Q1 2020 Financial Results
May 12, 2020
Sun BioPharma Announces Pause in Enrollment of Clinical Trial of SBP-101 for Patients with Pancreatic Cancer
April 3, 2020
Sun BioPharma Provides Business Update and Reports Operating Results for FY2019
March 24, 2020
Sun BioPharma, Inc. Initiates Search for CEO
January 28, 2020
Sun BioPharma, Inc. Summarizes SBP-101 Phase 1 Clinical Data Presented at ASCO 2020 Annual Gastrointestinal Cancers Symposium
January 24, 2020
Decks in 2020
- Investor Presentation (December 2020)
Investor deck · 23 slides · December 2020
- Sun BioPharma — Investor Presentation (September 2020)
Investor deck · 23 slides · Sep 14, 2020